Rhonda Patrick· PhD
Are current GLP-1 agonist doses too high?
Loading…
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
Are current GLP-1 agonist doses too high?
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
So maybe we just come back to the dose that maybe that's where we can find a common ground for all the enthusiasts and those who are enthusiastic but also a little skeptical on on my end where I am enthusiastic but I also just want to bring in a note of caution maybe where we do have that common ground is the dose.